Article
Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthma?
Minerva medica - 1 Oct 2015
Calabrese C, Carpagnano G E, Patella V, Vatrella A, Santus P
Abstract excerpt
Carraro et al. measured asymmetric dimethylarginine (ADMA) in the exhaled breath condensate (EBC) obtained from children with asthma and from healthy subjects. The authors demonstrated higher levels of ADMA in EBC of asthmatics compared to controls. ADMA levels in EBC did not correlate with serum levels, lung function parameters, and fractional exhaled nitric oxide. ADMA levels in EBC did not significantly differ...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.